{{Rsnum
|rsid=1545985
|Gene=FYCO1
|Chromosome=3
|position=45963986
|Orientation=plus
|GMAF=0.1919
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=FYCO1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 43.4 | 38.9 | 17.7
| HCB | 99.3 | 0.7 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 74.1 | 23.8 | 2.0
| ASW | 61.4 | 35.1 | 3.5
| CHB | 99.3 | 0.7 | 0.0
| CHD | 99.1 | 0.9 | 0.0
| GIH | 29.7 | 49.5 | 20.8
| LWK | 62.7 | 32.7 | 4.5
| MEX | 79.3 | 19.0 | 1.7
| MKK | 55.1 | 35.9 | 9.0
| TSI | 53.9 | 38.2 | 7.8
| HapMapRevision=28
}}
[[rs1545985]] is one of seven SNPs found in a combined study of over 1,000 patients to be associated with increased risk for [[prostate cancer]]. The risk allele for this SNP is (G); and while the odds ratio was not specifically reported, the probability of false significance (not permuted though) was given as p=6.6 x 10e-6, using an additive model of risk.{{PMID|18073375}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}